Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 7 studies | 29% ± 8% | |
oligodendrocyte precursor cell | 5 studies | 32% ± 11% | |
epithelial cell | 3 studies | 31% ± 10% | |
glutamatergic neuron | 3 studies | 43% ± 20% |
Insufficient scRNA-seq data for expression of USP43 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 515.10 | 328 / 328 | 94% | 5.74 | 167 / 178 |
prostate | 94% | 1733.85 | 230 / 245 | 100% | 19.39 | 501 / 502 |
lung | 98% | 662.08 | 564 / 578 | 90% | 6.45 | 1043 / 1155 |
thymus | 100% | 417.07 | 650 / 653 | 82% | 3.99 | 497 / 605 |
kidney | 100% | 639.67 | 89 / 89 | 79% | 4.34 | 716 / 901 |
stomach | 74% | 270.08 | 264 / 359 | 95% | 8.27 | 273 / 286 |
brain | 89% | 448.45 | 2354 / 2642 | 76% | 7.69 | 534 / 705 |
breast | 61% | 377.86 | 282 / 459 | 93% | 6.21 | 1041 / 1118 |
intestine | 53% | 402.77 | 511 / 966 | 98% | 8.49 | 516 / 527 |
bladder | 43% | 147.81 | 9 / 21 | 95% | 7.06 | 478 / 504 |
esophagus | 39% | 369.50 | 562 / 1445 | 98% | 10.52 | 180 / 183 |
liver | 100% | 832.40 | 225 / 226 | 35% | 2.46 | 143 / 406 |
uterus | 26% | 132.59 | 44 / 170 | 86% | 8.81 | 393 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.43 | 1 / 1 |
skin | 86% | 352.25 | 1557 / 1809 | 11% | 0.43 | 50 / 472 |
ovary | 5% | 9.33 | 9 / 180 | 88% | 4.38 | 380 / 430 |
tonsil | 0% | 0 | 0 / 0 | 91% | 7.02 | 41 / 45 |
spleen | 23% | 29.19 | 55 / 241 | 0% | 0 | 0 / 0 |
adipose | 18% | 27.78 | 211 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 10% | 12.43 | 26 / 258 | 4% | 0.15 | 9 / 230 |
eye | 0% | 0 | 0 / 0 | 11% | 0.33 | 9 / 80 |
peripheral blood | 7% | 10.74 | 66 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.07 | 1 / 29 |
heart | 1% | 0.84 | 6 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.74 | 7 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019985 | Biological process | translesion synthesis |
GO_0006508 | Biological process | proteolysis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0019785 | Molecular function | ISG15-specific peptidase activity |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP43 |
Protein name | Ubiquitin specific peptidase 43 Ubiquitin carboxyl-terminal hydrolase 43 (EC 3.4.19.12) (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43) |
Synonyms | |
Description | FUNCTION: May recognize and hydrolyze the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins (By similarity). . |
Accessions | V9GXZ5 ENST00000570475.5 [Q70EL4-4] V9GZ20 Q70EL4 ENST00000574408.5 ENST00000285199.12 [Q70EL4-1] ENST00000573955.1 |